Mann JFE, rsted DD, Brown-Frandsen K, Marso SP, Poulter NR, Rasmussen S, et al
Peptides like BPC-157 and Thymosin Beta-4 are increasingly used in sports and orthopedic medicine for chronic elbow pain
By targeting mitochondrial dysfunction, semaglutide may address a fundamental deficit in RV failure, potentially slowing disease progression in PH patients
In clinical trials of obese patients, tirzepatide showed even more impressive results in terms of weight loss from baseline, with an average reduction of 20-24%, and in some cases more than 30%, and became the first drug to outperform bariatric surgery (surgical procedures on the stomach and intestines aimed at treating obesity) in terms of effectiveness in studies